techMARK (TASX)

4,756.71
   
  • Change Today:
    -17.83
  • 52 Week High: 4,939.15
  • 52 Week Low: 4,135.10

Latest ShareCast News

GSK's COPD treatment approved by FDA

By Benjamin Chiou

Date: Friday 23 May 2025

(Sharecast News) - Pharma group GSK has announced that US regulators have approved for use its Nucala treatment for adults with chronic obstructive pulmonary disease (COPD) following positive results from phase III trials.

techMARK Regulatory News

Transaction in Own Shares 23-May-2025 17:38 RNS
Form 8.3 - Spirent Communications plc 23-May-2025 15:25 Business Wire
Form 8.3 - Spirent Communications plc 23-May-2025 15:20 RNS
Form 8.3 - SPIRENT COMMUNICATIONS PLC 23-May-2025 15:00 Business Wire
Form 8.3 - Spirent Communications PLC 23-May-2025 14:40 RNS

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Price Data

Price 4,756.71
Change Today -17.83
% Change -0.37 %
23-May-25 Close 4,756.71

Top Risers

Price Change
OXB 320.00p +5.4%
BVC 16.68p +3.9%
DIA 111.50p +1.8%
GNS 2,030.00p +1.6%
NCC 157.60p +0.6%
FLTR 17,820.00p +0.3%
SN. 1,063.00p +0.2%
SPT 193.80p +0.1%
BA. 1,843.00p +0.1%

Top Fallers

Price Change
TRD 275.00p -5.2%
APTD 278.00p -4.1%
RM. 94.00p -3.6%
XPP 760.00p -3.1%
OXIG 1,798.00p -2.7%
VOD 77.10p -2.3%
SXS 1,952.00p -2.1%
CCC 2,506.00p -1.6%
RCDO 273.00p -1.4%
XAR 105.00p -1.4%

Top of Page